December 16, 2022 from High Times Magazine Information collected in the “Global Hemp Market by Type” report from Research and Markets, which analyzed the numerous applications of hemp as a textile, food item, construction material, and more. The report projects that the next five years will see the industry’s compound annual growth rate (CAGR) of 21.6%, suggesting that this percentage
Continue reading 
December 29, 2022 from CannaReporter O French Council of State announced today that it has annulled the decree of December 30, 2021, which prohibited the sale of hemp flowers and leaves with a THC content of less than 0,3%. The decision emphasizes that “CBD cannot be considered a narcotic”, because “it does not have psychotropic effects or cause dependence”. The
Continue reading December21, 2022from RedaktionsNetzwerk Deutschland In order to urge Health Minister Karl Lauterbach (SPD) to act quickly on cannabis release, the budget politicians of the traffic light coalition have blocked funds. Because there is still no draft law, this now has consequences for Lauterbach. It was an unusual process: In the budget consultations for 2022, the budget politicians of the traffic
Continue reading 
December 26, 2022 from CannaReporter The National Center for Agro-Food Technology (CTAEX) received accreditation from the Spanish National Accreditation Entity (ENAC) to analyze medicinal cannabis and industrial hemp. The ceremony took place last week in the press room of the Ministry of Agriculture, Rural Development, Population and Territory of the Junta de Extremadura, and was attended by the general director
Continue reading 
December 19, 2022from CannaReporter The vice-president of the Parliamentary Group of the Socialist Party, Miguel Costa Matos, suggested to the Portuguese government to take advantage of the absolute majority it holds in the Assembly of the Republic to legalize cannabis. Miguel Costa Matos spoke during the National Congress of Socialist Youth, which ended yesterday in Braga, and where he was
Continue reading 
December 17, 2022 from Cureus Medical marijuana treatment for migraine is becoming more common, although the legality and societal acceptance of marijuana for medical purposes in the United States have been challenged by the stigma attached to it as a recreational drug. These substances function to reduce nociception and decrease the frequency of migraine by having an impact on the
Continue reading 
December 17, 2022 from ICBC Ireland’s Oireachtas Justice Committee is recommending that the government consider legalizing cannabis for adult-use, in addition to wider drug policy reforms. According to its website, the Oireachtas Justice Committee “shadows the Department of Justice and considers policy in the fields of justice, security and the rule of law to ensure that Irish society is safe,
Continue reading 
December 17, 2022 from ICBC All eyes remain on Germany where the adult-use legalization effort continues. For those that may not be up to speed, back in October the framework for a long-awaited legalization measure was presented by Germany’s Commissioner on Narcotic Drugs at the Federal Ministry of Health Burkhard Blienert to the nation’s federal cabinet. Since the formal presentation,
Continue reading 
December 22, 2022 from Marijuana Moment and NuggMD Nugg MD, a cannabis technology company that links people to doctors via telemedicine for medical cannabis recommendations, shared the results of the analysis exclusively with Marijuana Moment. The dataset was based on more than 210,000 anonymized patient records. One of the key findings concerns health conditions that people cite as the reason
Continue reading 
December 16, 2022 from Healio – Nephrology News & Issues According to data published in Kidney Medicine, there is no evidence that cannabis use causes chronic kidney disease, and researchers of the study suggest CKD should not be a limiting factor for cannabis use. A total of 80,132 participants reported lifetime cannabis use, none of which were significantly associated with
Continue reading
